Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.

A-rated James Hanbury trims short bet against Scottish Mortgage

Hanbury has cut his short position in Scottish Mortgage after its 60% plunge from a November 2021 peak, an indication that he and other bears of the £9bn trust think the worst may be behind it.

James Carthew: Float your eyes over these standout debt funds

Interest rate rises have given some London-listed debt funds a new lease for life and amid the market uncertainty there are good portfolios trading on attractive discounts.

James Carthew: Float your eye over debt funds

Interest rate rises have given some London-listed debt funds a new lease for life and amid the market uncertainty there are good portfolios trading on attractive discounts.

Baillie Gifford: We’ve got the right resources to do private equity for Scottish Mortgage

Stewart Heggie, Baillie Gifford's commercial director for Scottish Mortgage, refutes the accusation from the trust's boardroom rebel, Amar Bhidé, that the fund manager lacks the resources to invest in unquoted companies.

Artemis hires Columbia Threadneedle manager ahead of Edelsten exit

Artemis has bolstered the global team behind the Mid Wynd investment trust with another hire ahead of Simon Edelsten’s retirement at the end of the year.

3i Group reports Action sales up 25%, rest of portfolio resilient

FTSE-listed private equity and infrastructure giant assuages anxieties over its enormous stake in discount retailer Action which has continued its momentum from 2022 with a strong start to the year.

Brevan Howard fund faces ‘worst’ ever month after SVB collapse

BH Macro, the bond and currency hedge fund that has proved something of a safe haven in the past three years, discloses a 4% drop in net asset value after collapse of Silicon Valley bank.

Now is a good time to buy, say Scottish Mortgage backers

Scottish Mortgage fund managers and board directors are under pressure after former non-exec Amar Bhidé broke ranks in a row over performance and oversight. Nevertheless, two professional investors are standing by the stock.

Cash-laden BioPharma Credit targets another 14% yield in 2023

Drugs company lender enjoyed 'impressive' 2022 paying out record dividends of 13.1 cents per share at a 13.8% yield, which it believes it can replicate if it can reinvest a $333m cash pile.

Cash-laden BioPharma Credit could repeat 14% yield in 2023

Drugs company lender defied last year's volatile markets to pay out record dividends of 13.1 cents per share at a 13.8% yield, which analysts believe it could replicate this year if it can reinvest a $333m cash pile.

Supermarket Income and HICL sign debt deals to lock in costs

Supermarket Income and HICL Infrastructure have refinanced their debt facilities, putting a lid on the rising cost of borrowing.

Simon Elliott: Investment trusts down but not out

Former Winterflood analyst and now JP Morgan director challenges the idea that the bubble for investment trusts has burst following last year's derating of the sector's share prices.